Our Capabilities
Navigate the path from discovery to clinical development.
Scientific Analysis
ACTRIS partners with clients to evaluate scientific and preclinical data, identify development priorities, and establish a roadmap for translating cell and gene therapy products into clinical studies.
Regulatory Facilitation
ACTRIS provides regulatory support for cell, tissue, and gene therapy products, guiding clients through key regulatory milestones from gap assessment and development planning to clinical trial submissions.
Process/Assay Development and Validation
Explore how ACTRIS supports the translation of novel therapies through process/assay development, validation and manufacturing scale-up.
Ancillary Material File
ACTRIS provides a curated repository of ancillary materials to support regulatory compliance and maintain product quality in cell, tissue, and gene therapy manufacturing.
Technology Transfer
Facilitate the seamless transfer of manufacturing processes into ACTRIS with technical expertise, quality oversight, and regulatory compliance at every stage.
Release Assay
Assess cell and gene therapy products through release assays covering identity, purity, potency, sterility, and dosage, with options for both in-house and customised assay development.
Education and Training
Explore ACTRIS's education and training programmes designed to build capabilities across the cell, tissue and gene therapy ecosystem through knowledge sharing, skills development and hands-on learning.